HomeOwner SearchCategory Search
Visit USCOColloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis
Text Registration
Copyright Title
Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis
Status
Published
on 2 Dec 2020
Year of Creation
2020
Copyright Claimant
Journal of Drugs in Dermatology (JDD)
Registration Number
TX0008925133
on 2 Dec 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008925133) dated 2 Dec 2020, pertains to an electronic file (eService) titled "Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis" created in 2020. The copyright holder is Journal of Drugs in Dermatology (JDD), known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Journal of Drugs in Dermatology (JDD).
Application Details
Registration Number
TX0008925133
Registration Date
12/2/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Journal of Drugs in Dermatology (JDD)
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISSN
1545 9616
Notes
Rights Note: Caroline Barrett, Journal of Drugs in Dermatology (JDD), 115 E 23rd Street, 3rd Floor, Unit 322, New York, NY, 10010, United States, (646) 736-4330, caroline.barrett@sanovaworks.com
Host Item Entry: The Biological Impact of Oats: Eczema and Beyond October 2020, Volume 19, Issue 10 (Supplement)
Local Copyright Note: Regarding title information: Title of larger work added by Copyright Office from deposit.?Regarding authorship information: Copy contains no artwork. Registered as a literary work containing text and figure
Statements
Application Title Statement: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis
Author Statement: Journal of Drugs in Dermatology (JDD) employer for hire Citizenship: United States Authorship: text, artwork
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.